Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 36 (1) , 327-335
Abstract
Purpose: To assess the efficacy of the albumin-bilirubin (ALBI) grade on assessing long-term outcomes of computed tomography (CT)-guided percutaneous microwave ablation (CT-PMWA) in the treatment of patients with intrahepatic cholangiocarcinoma (ICC). Methods: Between April 2011 and March 2018, 78 patients who underwent CT-PMWA were enrolled in this study. Overall survival (OS) and recurrence-free survival (RFS) were compared in the groups stratified by the ALBI grade and Child–Pugh score. Cox proportional hazard regression analyses were performed to determine independent predictors of OS and RFS. Results: After a median follow-up of 22.7 months (range 1–86.7 months), 67 patients had died. The cumulative 1-, 3-, and 5-year OS rates were 89.5%, 52.2%, and 35.0%, respectively. Stratified by the ALBI grade, the cumulative 1-, 3-, and 5-year OS rates were 100%, 69.2%, and 25.6% for patients with the grade 1, respectively. For patients with the ALBI grade 2, the cumulative 1-, 3-, and 5-year OS rates were 41.0%, 10.3%, and 10.3%, respectively. Patients with a hepatic function of the ALBI grade 1 had significantly higher OS rates than patients with the ALBI grade 2 (p < .001). The multivariate analysis showed tumor size (Hazard Ratio[HR] 95% Confidence Interval[CI]:9.03[1.01–80.52], p = .049) and the ALBI grade (HR[95%CI]:9.56[1.58–58.00], p = .014) were associated with OS, and tumor size (HR: 2.03[0.69–8.04], p = .049) was associated with RFS. Conclusions: The preliminary data of this study showed the ALBI grade was effective to predict long-term outcomes of CT-PMWA in ICCs. Further study is necessary to validate our results by a large, multi-center patient cohort.Keywords
Funding Information
- Scientific Research Foundation of Medical Science of Guangdong Province, China (A2018267)
- Guangdong Provincial Department of Science and Technology (2017B030314026)
This publication has 29 references indexed in Scilit:
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaJournal of Hepatology, 2017
- Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinomaOncotarget, 2016
- Prognosis of Early-Stage Hepatocellular CarcinomaMedicine, 2015
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Hepatocellular carcinoma review: Current treatment, and evidence-based medicineWorld Journal of Gastroenterology, 2014
- Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic ResectionAnnals of Surgical Oncology, 2014
- Cholangiocarcinoma: lessons from ThailandCurrent Opinion in Gastroenterology, 2008
- Assessment of Prognosis of CirrhosisSeminars in Liver Disease, 2008
- Percutaneous Ultrasound‐guided Radiofrequency Ablation of Intrahepatic CholangiocarcinomaThe Kaohsiung Journal of Medical Sciences, 2005
- Hepatocellular Carcinoma: US-guided Percutaneous Microwave Coagulation TherapyRadiology, 2001